Blockade of adenosine A2A receptor enhances CD8(+) T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma

BACKGROUND: Cancer immunotherapy offers a promising approach in cancer treatment. The adenosine A2A receptor (A2AR) could protect cancerous tissues from immune clearance via inhibiting T cells response. To date, the role of A2AR in head and neck squamous cell carcinoma (HNSCC) has not been investiga...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Si-Rui, Deng, Wei-Wei, Liu, Jian-Feng, Mao, Liang, Yu, Guang-Tao, Bu, Lin-Lin, Kulkarni, Ashok B., Zhang, Wen-Feng, Sun, Zhi-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461710/
https://www.ncbi.nlm.nih.gov/pubmed/28592285
http://dx.doi.org/10.1186/s12943-017-0665-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461710/
https://www.ncbi.nlm.nih.gov/pubmed/28592285
http://dx.doi.org/10.1186/s12943-017-0665-0

Ejemplares similares